tigatx-announces-up-to-35-5m-in-funding-from-arpa-h-and-nih-awards-to-advance-first-in-class-engineered-iga-monoclonal-antibody-for-cancer-and-infectious-diseases

TigaTx Announces up to $35.5M in Funding from ARPA-H and NIH Awards to Advance First-in-Class Engineered IgA Monoclonal Antibody for Cancer and Infectious Diseases

Dec 19, 2024